Our small-batch synthesis guarantees the exact amino-acid sequencing required for legitimate study
capsules are easier for consistent dosing Note on higher doses: Some researchers in the community are experimenting with significantly higher doses (100300mg+)
Health officials are optimistic, barring a new mutant
not primarily appetite-driven (OUP Academic) Expected weight loss (this is where many people get misled) In major obesity trials: Semaglutide 2.4 mg weekly: ~14.9% mean weight loss at 68 weeks (STEP-1) (PubMed) Tirzepatide: ~15.0% to ~20.9% mean weight loss at 72 weeks , dose-dependent (SURMOUNT-1) (PubMed) AOD-9604s best-known human signal is kilograms, not double-digit percentages , and later studies did not sustain a strong obesity-drug profile
The therapy is unglamorous, the science is settled, and it works
For those targeting specific problem areas, understanding peptides for visceral fat loss provides additional context